As of 10:30 AM on the 28th, Jinwon Life Sciences is trading at 25,050 KRW, up 1.83% from the previous day. This is a 26.65% decrease compared to September 24. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Today, foreigners are tentatively recorded as net sellers of 4,000 shares. Over the past five days, individual investors have net sold 59,360 shares, while foreigners and institutions have net bought 66,844 shares and net sold 13,385 shares, respectively.
On October 26, Jinwon Life Sciences became a market issue with an 8% drop due to 'institutional and foreign selling.'
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
